The Trump administration's freeze on communications, travel, and diversity efforts has sowed chaos across federal health ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...